Jpmorgan Chase & Co »

Travere Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $81k 125k 0.65
2023-09-30 $81k 125k 0.65
2023-06-30 $102k 125k 0.81
2023-03-31 $123k 125k 0.98